Feature Channels: Autoimmune Diseases

Filters close
Released: 1-Aug-2023 5:30 PM EDT
Three doses of COVID-19 vaccine leads to catch-up antibody responses among the particularly vulnerable
University of Gothenburg

Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine.

Newswise: Illinois Team Identifies Key Driver of Cancer Cell Death Pathway That Activates Immune Cells
Released: 31-Jul-2023 11:50 AM EDT
Illinois Team Identifies Key Driver of Cancer Cell Death Pathway That Activates Immune Cells
College of Liberal Arts and Sciences, University of Illinois Urbana-Champaign

University of Illinois scientists have identified a protein that plays a critical role in the action of several emerging cancer therapies. The discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging cancers.

   
Newswise: Researchers Discover Genetic Locations for Increased Risk of Hidradenitis Suppurativa
Released: 26-Jul-2023 3:05 PM EDT
Researchers Discover Genetic Locations for Increased Risk of Hidradenitis Suppurativa
University of North Carolina School of Medicine

Hidradenitis suppurativa (HS) is a chronic inflammatory follicular disease which causes painful lumps to form under the skin. The lumps typically form in areas where skin rubs together – such as the armpits, groin, and under the breasts. HS can range in severity from occasional fluid-filled abscesses to widespread rope-like scarring, chronic pain, and increase of infection.

24-Jul-2023 9:10 AM EDT
Experts call for urgent mental health support for people living with long term autoimmune diseases
University of Cambridge

Study finds ‘startling’ levels of hidden mental health symptoms among autoimmune disease patients.

19-Jul-2023 10:00 AM EDT
Artificial Intelligence Models Predict Multiple Sclerosis, Detect Contaminated Lab Samples
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A new artificial intelligence model can predict people’s risk of multiple sclerosis years before diagnosis, potentially enabling quicker treatment, according to research revealed today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo.

Released: 24-Jul-2023 12:05 PM EDT
Technology Developed at Rutgers Sublicensed to Global Biopharmaceutical Company
Rutgers University's Office for Research

Base editing technology invented at Rutgers, The State University of New Jersey, and exclusively licensed to Revvity, Inc. subsidiary Horizon Discovery, has been sub-licensed to biopharmaceutical company AstraZeneca to support its creation of cell therapies for the treatment of cancer and immune-mediated diseases.

Released: 19-Jul-2023 1:05 PM EDT
Researchers Report Advance in Immune Therapy Against ALS
Federation of American Societies for Experimental Biology (FASEB)

New research suggests that targeting autoimmune inflammation associated with amyotrophic lateral sclerosis (ALS) using two drugs, one of them already approved for multiple sclerosis, could be a promising approach for treatment.

Newswise: The double face of RNase as a treatment for systemic autoimmune diseases
Released: 18-Jul-2023 10:45 AM EDT
The double face of RNase as a treatment for systemic autoimmune diseases
Osaka University

Systemic autoimmune diseases are characterized by inflammation of multiple organs and can have devastating consequences for patients. There is a dire need for treatments against these diseases.

Released: 12-Jul-2023 6:30 PM EDT
Researchers report advance in immune therapy against ALS
University of California, Los Angeles (UCLA), Health Sciences

New research suggests that targeting autoimmune inflammation associated with amyotrophic lateral sclerosis (ALS) using two drugs, one of them already approved for multiple sclerosis, could be a promising approach for treatment.

Newswise: UM Neurologists Lead Groundbreaking Myasthenia Gravis Cellular Therapy Study Published in Lancet Neurology
Released: 30-Jun-2023 1:05 PM EDT
UM Neurologists Lead Groundbreaking Myasthenia Gravis Cellular Therapy Study Published in Lancet Neurology
University of Miami Health System, Miller School of Medicine

A new study led by two neurologists at the University of Miami Miller School of Medicine points to a potential novel form of Car T cellular therapy for myasthenia gravis (MG), a chronic autoimmune disorder characterized by muscle weakness. The study findings were recently published in the British journal Lancet Neurology.

Newswise:Video Embedded proteins-predict-significant-step-toward-development-of-diabetes
VIDEO
28-Jun-2023 3:00 PM EDT
Proteins Predict Significant Step Toward Development of Diabetes
Pacific Northwest National Laboratory

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Newswise:Video Embedded scleroderma-awareness-month
VIDEO
Released: 27-Jun-2023 12:30 PM EDT
Scleroderma Awareness Month
Cedars-Sinai

Scleroderma is an autoimmune disease characterized by thickening and scarring of the skin and vital organs, and the narrowing of the blood vessels which lead to poor circulation.

Newswise: UTHealth Houston Study on Repeated Radiofrequency Ablation in Combination with Chemotherapy for Pancreatic Cancer Supported with $3.3M HHS Grant
Released: 20-Jun-2023 5:25 PM EDT
UTHealth Houston Study on Repeated Radiofrequency Ablation in Combination with Chemotherapy for Pancreatic Cancer Supported with $3.3M HHS Grant
University of Texas Health Science Center at Houston

A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.

Released: 20-Jun-2023 5:20 PM EDT
Rensselaer Researcher To Investigate the Mechanics of Mitosis To Combat Cancer
Rensselaer Polytechnic Institute (RPI)

It is a scary fact that one in two women and one in three men in the United States will develop some form of cancer in their lifetime. One of the hallmarks of many cancers is the occurrence of errors during the cell division process called mitosis. Therefore, critical to enhancing treatments or perhaps even finding a cure for cancer and other diseases, is developing a better understanding of how mitosis works in both healthy and diseased cells.

Released: 13-Jun-2023 1:10 PM EDT
Why women with multiple sclerosis get better when pregnant
Linkoping University

Women suffering from the autoimmune disease multiple sclerosis temporarily get much better when pregnant. Researchers have now identified the beneficial changes naturally occurring in the immune system during pregnancy.

Newswise: SLU Medical Student Receives NIH F30 Grant to Explore Autoimmune Disease, Infection in the Stomach
Released: 8-Jun-2023 5:00 PM EDT
SLU Medical Student Receives NIH F30 Grant to Explore Autoimmune Disease, Infection in the Stomach
Saint Louis University

Stella Hoft, a M.D./Ph.D. student at Saint Louis University’s School of Medicine, was recently awarded a F30 Grant through the National Institute of Diabetes & Digestive & Kidney Diseases.

Newswise: SLU Researcher Receives $2.2 M to Study Link Between Inflammation, Gastric Cancer
Released: 8-Jun-2023 4:30 PM EDT
SLU Researcher Receives $2.2 M to Study Link Between Inflammation, Gastric Cancer
Saint Louis University

Rich DiPaolo, Ph.D., professor and interim chair in the Department of Molecular Microbiology and Immunology, warns that patients with gastritis caused by autoimmunity as well as Helicobacter pylori, a type of bacteria that infects your stomach, may benefit from routine screenings to identify patients with a high risk of progressing to gastric cancer.

Released: 8-Jun-2023 7:00 AM EDT
Usar IA para predecir la insuficiencia renal en pacientes con enfermedad renal poliquística
Mayo Clinic

La insuficiencia renal puede tener diversas causas: diabetes, presión arterial alta, enfermedades autoinmunitarias y enfermedad renal poliquística o ERP.



close
2.03423